Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
/
Clinical Visual Analytics for Review and Submission (CVARS)

    Clinical Visual Analytics for Review and Submission (CVARS)

    Oct 01, 2025

    Project Scope

    Development of an open-source tool and package to enable generation of identified interactive plots for clinical review and direct inclusion in submissions to regulatory agencies. The initial scope is to develop a package to generate interactive forest and volcano plots for adverse events and FDA Medical Queries (FMQs) analysis outputs for inclusion in submissions to the FDA. This work is a collaboration among the American Statistical Association (ASA), PHUSE and the FDA.

    Project Leads

    Email

    Melvin Munsaka, AbbVie

    melvin.munsaka@abbvie.com

    Jiang (Jessica) Hu, FDA

    jiang.hu@fda.hhs.gov

    Neetu Sangari, Pragya Tech Leadersneetusang@gmail.com
    Alex Pearce, PHUSE Project Assistant

    alexandra@phuse.global

    CURRENT STATUS (Updated Quarterly) 

    • Draft code snippets for additional CVARS functionality

    • Team presented at Tarrytown SDE 

    • Updated CVARS tool and vignette​​​

    Objectives & DeliverablesTimelines
    An open-source R Shiny tool for generating the plots and associated outputs and an accompanying paper for the toolQ3 2022
    Complete manuscriptQ4 2024
    Resources 
    CVARS GitHub Page
    CVARS


    , multiple selections available,
    Welcome to the PHUSE Advance Hub

    WORKING GROUPS
    Results will update as you type.
    • Working Groups
      • Data Transparency
      • Data Visualisation & Open Source Technology
        • Clinical Visual Analytics for Review and Submission (CVARS)
        • Communication of Version Metadata for Open-Source Languages
        • Comparing Analysis Method Implementations in Software (CAMIS)
        • Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework
        • Teal Enhancements for Cross-Industry Adoption
      • Emerging Trends & Innovation
      • Nonclinical Topics
      • Optimizing the Use of Data Standards
      • pharmaverse
      • Real World Evidence
      • Risk Based Quality Management
      • Safety Analytics
    • Hot Topics
    • Useful Information
    • Deliverables
    • Working Groups Events
    • Working Groups Report – Q3 2025
    • Working Groups Archive
    • Working Groups Events Archive

      You‘re viewing this with anonymous access, so some content might be blocked.
      {"serverDuration": 11, "requestCorrelationId": "f876076dceb64d40b30aedc3c5b7ccec"}